Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systems biology study of variability in immune responses to BCG vaccination
NL-OMON45603Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of bcg vaccine in Tuberculosis (TB) and leprosy (HD), sponsored by Radboud University Medical Center. Primary endpoints: Immune cell function, Genetic variation and 2 more. Started Apr 2017; status: active, not recruiting.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)leprosy (HD)
Beyond the preview
Go deeper on NL-OMON45603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45603.